Drug Trial Radar · NCT07349381
A Food-Effect Study of CX11 in Healthy Participants
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Mar 4, 2026
Primary completion
Jun 30, 2026
Study completion Aug 30, 2026
Sponsor
- Lead sponsor
- Vincentage Pharma Co., LtdIndustry
- Sponsor type
- Industry
- Collaborators
- Corxel Pharmaceuticals
- First posted
- Jan 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is to evaluate the food effect (FE) on the PK of 200 mg CX11 in healthy participants
Conditions
- Obesity & Overweight
- Type 2 Diabetes
Interventions
CX11 (VCT220)Drug
CX11 (VCT220) administered orally to participants who are in fasted/fed state in the first 6 consecutive days, and in fed/fasted state on the 7th day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Concentration-time curve from 0 to 24 hour (AUC0-24) of CX11 (VCT220)Time frame: Predose at Day1 up to 35 days postdose
- Maximum Observed Concentration (Cmax) of CX11 (VCT220)Time frame: Predose at Day1 up to 35 days postdose
- Time to Maximum Observed Concentration (Tmax) of CX11 (VCT220)Time frame: Predose at Day 1 up to 35 days postdose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shanghai Xuhui Central Hospital
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.